Randomized Intravenous Tezosentan for the Treatment of Acute Heart Failure - RITZ 2

Description:

The goal of the trial was evaluate the hemodynamic effects of 2 doses of tezosentan in a large patient population with acute decompensated heart failure (ADHF) and to confirm positive results observed in phase II trials.